TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ARDX

Ardelyx Inc

Healthcare · Biotechnology

3.40$ +1.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Ardelyx Inc (ARDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 121 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ARDX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
56 34 46 73 98 116 74 98 110 125 94 121 451
7.7 5.1 7.6 10 16 18 13 13 4.9 12 4.8 5.8 27
49 29 38 63 83 98 61 85 105 113 90 115 424
8.6 9.5 10 12 15 14 14 15 17 22 20 26 85
33 48 53 65 65 76 83 84 84 86 102 101 374
41 57 63 77 80 90 98 99 101 108 122 128 459
7.4 -28 -25 -14 2.2 8.1 -36 -14 4.7 5.1 -33 -12 -35
2.0 2.8 4.1 4.9 5.3 5.9 6.3 6.6 8.0 7.6 6.9 5.0 27
6.8 -28 -26 -16 -0.8 4.7 -40 -19 -0.9 -0.4 -38 -17 -55
0.2 0.3 0.1 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.2
6.6 -29 -27 -16 -0.8 4.6 -41 -19 -1.0 -0.4 -38 -17 -56
9.1 -25 -22 -11 5.1 11 -33 -12 8.0 8.1 -30 -10 -24

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?